Vext Science, Inc.
VEXT
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.19M | 8.99M | 8.43M | 8.39M | 8.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.19M | 8.99M | 8.43M | 8.39M | 8.42M |
| Cost of Revenue | 8.06M | 5.02M | 6.87M | 7.06M | 6.55M |
| Gross Profit | 2.14M | 3.97M | 1.55M | 1.33M | 1.87M |
| SG&A Expenses | 2.84M | 3.01M | 3.01M | 2.57M | 7.49M |
| Depreciation & Amortization | 2.19M | 2.25M | 2.30M | 2.00M | 2.03M |
| Other Operating Expenses | 374.00K | -- | -- | -- | -1.00K |
| Total Operating Expenses | 13.46M | 10.28M | 12.19M | 11.63M | 16.07M |
| Operating Income | -3.27M | -1.29M | -3.76M | -3.24M | -7.66M |
| Income Before Tax | -7.20M | -2.74M | -4.52M | -6.67M | 7.94M |
| Income Tax Expenses | 2.02M | -238.80K | -127.20K | -340.50K | 2.31M |
| Earnings from Continuing Operations | -9.22M | -2.50M | -4.39M | -6.33M | 5.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.22M | -2.50M | -4.39M | -6.33M | 5.63M |
| EBIT | -3.27M | -1.29M | -3.76M | -3.24M | -7.66M |
| EBITDA | 345.50K | 2.35M | -50.90K | 197.40K | -4.35M |
| EPS Basic | -0.04 | -0.01 | -0.02 | -0.03 | 0.03 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.04 | -0.01 | -0.02 | -0.03 | 0.03 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 247.44M | 245.55M | 245.45M | 225.13M | 209.13M |
| Average Diluted Shares Outstanding | 247.44M | 248.66M | 245.45M | 225.36M | 210.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |